Health Care & Life Sciences » Biotechnology | Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd. ADR | Ownership

Companies that own Cellect Biotechnology Ltd. ADR

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Sabby Capital LLC
111,540
2.06%
-132,440
0.3%
06/30/2018
G1 Execution Services LLC
49,365
0.92%
-6,533
0.02%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
16,864
0.31%
2,000
0%
06/30/2018
Susquehanna Investment Group LLC
12,064
0.22%
0
0%
06/30/2018
Citigroup Global Markets, Inc. (Investment Management)
9,740
0.18%
0
0%
06/30/2018
Migdal Mutual Funds Ltd.
1,555
0.03%
0
0%
12/31/2017
UBS Securities LLC
1,520
0.03%
1,520
0%
06/30/2018
CIBC Private Wealth Advisors, Inc.
50
0%
0
0%
06/30/2018
Morgan Stanley & Co. LLC
5
0%
0
0%
06/30/2018
Migdal Insurance Co. Ltd. (Investment Portfolio)
0
0%
-1,555
0%
06/30/2018

About Cellect Biotechnology

View Profile
Address
23 Hata'as Street
Kfar Saba JM 44425
Israel
Employees -
Website http://cellect.co
Updated 07/08/2019
Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.